Clinical Trial Update: Managing Endothelial Dysfunction in Critically Ill COVID-19 Patients at LAUMCRH [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on managing endothelial dysfunction in critically ill COVID-19 patients at LAUMCRH; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction

Snippet

Sponsor: Lebanese American University Medical Center | Conditions: Covid19, Endothelial Dysfunction | Phase 3 | Status: UNKNOWN